Core Viewpoint - A class action lawsuit has been filed against BellRing Brands, Inc. for allegedly misleading investors regarding the company's sales growth during the specified period [1][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who acquired BellRing securities from November 19, 2024, to August 4, 2025 [1]. - Investors have until March 23, 2026, to seek appointment as lead plaintiff representatives [2]. Group 2: Company Background - BellRing Brands is headquartered in St. Louis, MO, and markets nutrition products including ready-to-drink protein shakes, nutrition drinks, powders, and protein bars under the Premier Protein and Dymatize brands [2]. Group 3: Allegations - The lawsuit claims that BellRing, along with its CEO and CFO, misled investors about sales growth, attributing it to factors like "organic growth" and "strong macro tailwinds around protein," while downplaying competition's impact [3]. - Contrary to these statements, the complaint alleges that sales were primarily driven by inventory stockpiling by key customers [3].

Philadelphia, Pennsylvania--(Newsfile Corp. - February 20, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Enphase Energy, Inc. (NASDAQ: ENPH) ("Enphase" or the "Company") on behalf of investors who purchased or otherwise acquired Enphase securities during the period from April 22, 2025 through October 28, 2025 (the "Class Period").Investor Deadline: Investors who purchased Enphase securities during the Class Period may, no later than Ap ...

Core Viewpoint - An investigation is being conducted into Under Armour's Board of Directors for potential breaches of fiduciary duties related to cybersecurity events affecting the company's data systems [1]. Group 1: Company Overview - Under Armour, Inc. is a global sportswear and performance gear company based in Baltimore, MD, specializing in the design, development, marketing, and distribution of athletic apparel, footwear, and accessories worldwide [2]. Group 2: Legal Context - Berger Montague PC, a prominent law firm specializing in complex civil litigation, is advising Under Armour shareholders regarding the investigation into the Board's actions [1][3]. - The firm has a strong track record, having recovered over $50 billion for clients and represented in various legal areas including antitrust, consumer protection, and securities [3].

Core Viewpoint - A class action lawsuit has been filed against Ramaco Resources, Inc. (NASDAQ: METC) for allegedly misleading investors about the development progress of its projects, particularly the Brook Mine in Wyoming, leading to a significant drop in stock price following the revelation of these claims [1]. Company Overview - Ramaco Resources, Inc. is headquartered in Lexington, Kentucky, and operates coal and mineral development projects in the United States [1]. Lawsuit Details - The lawsuit pertains to investors who purchased Ramaco securities between July 31, 2025, and October 23, 2025, with a deadline of March 31, 2026, for potential lead plaintiff appointments [1]. - The complaint alleges that Ramaco overstated development progress at the Brook Mine, which was described as a "hoax" and a "Potemkin Mine" by Wolfpack Research, indicating no significant mining activity had occurred since its groundbreaking [1]. Stock Market Impact - Following the report by Wolfpack Research on October 23, 2025, Ramaco's stock price fell by $3.81, nearly 10%, closing at $36.01 per share, with unusually high trading volume [1].

Core Viewpoint - A class action lawsuit has been filed against Fermi Inc. on behalf of investors who acquired Fermi securities during the specified class period, highlighting potential issues with the company's disclosures and performance [1][4]. Group 1: Lawsuit Details - The lawsuit pertains to investors who purchased Fermi securities from October 1, 2025, to December 11, 2025, including during the company's initial public offering [1]. - Investors have until March 6, 2026, to seek appointment as lead plaintiff representatives of the class [2]. - The lawsuit claims that investors were misled about Fermi's prospects, particularly after the termination of a significant agreement related to Project Matador [4]. Group 2: Company Overview - Fermi Inc., based in Amarillo, Texas, aims to establish a network of large, grid-independent data centers powered by various energy sources, including nuclear, natural gas, solar, and battery energy [3]. - The flagship initiative, "Project Matador," is designed to create the world's largest private energy campus dedicated to powering AI data centers [3]. Group 3: Financial Impact - Following the announcement of the termination of a $150 million agreement for Project Matador, Fermi's stock price dropped by $5.16, nearly 34%, closing at $10.09 per share on December 12, 2025 [4].

PHILADELPHIA, Feb. 19, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces that a class action lawsuit has been filed against CoreWeave, Inc. (NASDAQ: CRWV) (“CoreWeave” or the “Company”) on behalf of investors who purchased or otherwise acquired CoreWeave securities during the period from March 28, 2025 through December 15, 2025 (the “Class Period”), inclusive. Investor Deadline: Investors who purchased CoreWeave securities during the Class Period may, no later than March 13 ...

Philadelphia, Pennsylvania--(Newsfile Corp. - February 18, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against uniQure N.V. (NASDAQ: QURE) ("uniQure" or the "Company") on behalf of investors who purchased or otherwise acquired uniQure securities during the period from September 24, 2025 through October 31, 2025 (the "Class Period"). Investor Deadline: Investors who purchased uniQure securities during the Class Period may, no later than Apri ...

Core Viewpoint - A class action lawsuit has been filed against Mereo BioPharma Group PLC, alleging that the company made misleading statements regarding its clinical trials for setrusumab, leading to significant financial losses for investors when the trials failed to meet their primary endpoints [1]. Company Overview - Mereo BioPharma Group PLC is a biopharmaceutical company based in London, UK, focused on developing therapies for rare and serious diseases [1]. Legal Proceedings - The class action lawsuit is on behalf of investors who purchased American Depositary Shares (ADS) from June 5, 2023, to December 26, 2025, with a deadline of April 6, 2026, for investors to seek lead plaintiff status [1]. - The lawsuit claims that Mereo issued overly positive statements about its ORBIT and COSMIC Phase 3 clinical trials for setrusumab, which ultimately did not achieve their primary endpoint of reducing the annualized clinical fracture rate [1]. Financial Impact - Following the disclosure on December 29, 2025, that the clinical trials did not meet their primary endpoints, Mereo's ADS price plummeted over 87%, from $2.31 per share on December 26, 2025, to $0.29 per share on December 29, 2025 [1].

Philadelphia, Pennsylvania--(Newsfile Corp. - February 18, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) ("Ultragenyx" or the "Company") on behalf of investors who purchased Ultragenyx common stock during the period from August 3, 2023 through December 26, 2025 (the "Class Period").Investor Deadline: Investors who purchased Ultragenyx common stock during the Class Period may, no later than ...

Core Viewpoint - An investigation is being conducted into Stride, Inc.'s Board of Directors for potential breaches of fiduciary duties, particularly regarding oversight and governance related to the company's public statements on operations and financial performance [1]. Company Overview - Stride, Inc., headquartered in Reston, Virginia, is an education technology company that provides online learning programs, curricula, and support services to schools and districts across the United States [2]. Legal Context - Berger Montague PC, a prominent law firm specializing in complex civil litigation, is advising shareholders of Stride regarding the investigation into the Board's actions [1][3]. - The firm has a significant track record, having recovered over $50 billion for clients and represented in various legal areas including antitrust and securities [3].